gly-230
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2005 (NCT00544921)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 2-(3-chlorophenylamino)phenylacetic acid
- 23cppa cpd
- gly-230
- gly-230
- gly-230
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00544934 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2007 | Glycadia, Suncoast Clinical Research, University of Florida, University of Miami |
| NCT00544921 | Phase 1 | Oct 1, 2005 | Glycadia, University of Florida |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Glycadia | For profit | 2 | 2 | 2 | 2005 |
| University of Florida | Academic/Hospital | 2 | 0 | 2 | 2005 |
| Suncoast Clinical Research | For profit | 1 | 0 | 1 | 2007 |
| University of Miami | Academic/Hospital | 1 | 0 | 1 | 2007 |
4 organizations
Page 1 / 1